Judge Blocks Pentagon AI Ban, Easing Palantir's $1.3B Maven Risk

A federal judge's ruling that the Pentagon's Anthropic ban was illegal removes a key execution risk from Palantir's Maven program.

Palantir faces lower execution risk on its Maven defense program after a federal judge permanently blocked the Pentagon's designation of Anthropic as a supply-chain risk, weeks before the program's September designation deadline.

Judge Rita Lin concluded the government retaliated after Anthropic resisted unrestricted use of Claude for mass surveillance and autonomous weapons, calling the designation illegal and baseless. "Maven continues to deliver for the joint force, from the factory floor to the foxhole," Shyam Sankar, chief technology officer at Palantir, said on the Q2 earnings call.

Palantir closed at $186.29 Friday, up 51.46% over the past month. U.S. government revenue grew 90% year-over-year to $809 million in Q2, while total revenue rose 93% with a Rule of Forty score of 155 and adjusted free cash flow of $1.22 billion.

The ruling does not require the Pentagon to retain Anthropic as a supplier or guarantee incremental Palantir revenue, and the government may appeal. But it shrinks the tail risk that Maven's model layer gets forcibly reshuffled before the program graduates to permanent funding status by the end of September.

Palantir was not a party to the case, so it receives no direct legal benefit. The practical effect is that Palantir likely avoids rewriting orchestration inside classified environments on a compressed timeline, which is expensive and slow. Timing matters more than total addressable market for program-of-record designations.

Maven's existing contract ceiling was raised to $1.3 billion in 2025, and Palantir separately holds an Army agreement worth up to $10 billion. A ceiling is the maximum the government may spend, not revenue Palantir has earned. The FY 2027 President's Budget requests $2.3 billion for the Maven Smart System and Joint Fires Network to deliver joint command and control, part of a $58.5 billion AI investment line item. Management said the Department of War trailing twelve-month revenue is "less than 25 basis points of the Pentagon's budget," and Maven now has over 25,000 builders using it.

The ruling also carries implications beyond Palantir. Anthropic's Claude is embedded across multiple defense contractors' systems, and the Pentagon's March designation had forced a scramble to identify alternative models. The court's decision removes that pressure for the broader supply chain, though the government's appeal option keeps some uncertainty alive.

Model Swaps Are a Feature, Not a Threat

Palantir's value sits in the integration layer above whichever frontier model the Pentagon picks. Sankar told analysts "We have a product that allows you to switch out models," and Alex Karp added "It's not about being beholden to one model. It's about bringing the right models to bear for the right purposes." Sankar also described bringing in NVIDIA's Nemotron Ultra and finding five production tasks where a standard Nemotron Ultra model without post-training beat frontier models within 24 hours. If AIP is the orchestration and evaluation surface, model swaps become a platform feature rather than a contract threat.

Forward P/E Near 110x Tests the Bull Case

Palantir trades at a forward P/E near 110x against a price-to-sales ratio of about 73x. Any bullish case must survive those numbers. The offset is growth quality. Q2 revenue rose 93% year-over-year with a Rule of Forty score of 155 and adjusted free cash flow of $1.22 billion. The market is not fully convinced this holds. Polymarket assigns its highest probabilities to $180 at 0.315 and $192 at 0.305, and the August 31 directional market leans Down at 0.53. The $191.68 average analyst target is barely above spot, so the sell side is not underwriting a fresh leg higher on this news alone.

The ruling lowers execution risk on Maven's path to program-of-record status without changing the valuation math. Watch the September designation closely, but do not expect overnight repricing.

This article is for informational purposes only and does not constitute investment advice.